• Место топических глюкокортикоидов в лечении дерматитов разной этиологии 
To content

Место топических глюкокортикоидов в лечении дерматитов разной этиологии 

HEALTH OF WOMAN. 2016.8(114):33–36 
 

Место топических глюкокортикоидов в лечении дерматитов разной этиологии 
 

Калюжна Л. Д.

Национальная медицинская академия последипломного образования имени П.Л. Шупика, г. Киев


В статье освещается информация относительно воспалительных заболеваний кожи – дерматитов, их видов, симптомов, причин возникновения и лечения.


Ключевые слова: атопический дерматит, местная терапия, комбинированные топические глюкокортикоиды, Тримистин®-Дарница.


Литература:

1. Belash NG. 2007. Topicheskie kortikosteroidyi v praktike semeynogo vracha. Mistetstvo lIkuvannya 3:53–54.

2. Derimedved LV, Vereitinova VP, Tarasenko OV, Zavgorodniy AA. 2004. Topicheskie steroidyi v praktike semeynogo vracha. Provizor, 12 (http://www.provisor.com.ua/ archive/2004/N12/art_31.php).

3. Zaichenko YaO. 2004. Atopichnyi dermatyt: mozhlyvi prychyny, patohenez, klinika. Ukr. med. chasopys 5(43):21–23.

4. Zubarenko AV, Portnova OA. 2009. Atopicheskiy dermatit. Kontseptsiya effektivnoy terapii. Zdorove rebenka 3(18):103–108.

5. Kalyuzhnaya LD. 2003. Aktualnaya problema dermatovenerologii – atopicheskiy dermatit. Ukr. med. chasopis 2(34):87–91 (http://www.umj.com.ua /article/1227).

6. Kalyuzhnaya LD. 2014. Printsipyi topicheskoy terapii atopicheskogo dermatita. Ukr. med. chasopis 5(103):59–61 (http://www.umj.com.ua/article/80448).

7. Kompendium – lekarstvennyie preparatyi. 2015. Pod red. VN Kovalenko. MORION, Kiev (http://compendium.com.ua/info/29594/trimistin-sup-sup-darnitsa).

8. Kutasevich YaF. 2000. Sovremennyie podhodyi k primeneniyu topicheskih glyukokortikosteroidov. Zhurnal dermatologii i venerologii 1:95–99.

9. Kutasevich YaF, Umanets TR. 2014. Effektivnost i bezopasnost primeneniya topicheskih ingibitorov kaltsinevrina v pediatrii. Ukr. med. chasopis 3(101):46–53 (http://www.umj.com.ua/article/74684).

10. Pertsev IM, Derimedved LV, Haleeva EL, Chueshov OV. 2002. Primenenie kortikosteroidnyih mazey pri mestnom lechenii dermatozov. Provizor 7:17–20.

11. Suvorova KN. 1988. Atopicheskiy dermatit: immunopatogenez i strategiya immunoterapii. RMZh (Russkiy meditsinskiy zhurnal) 6:363–395.

12. Shupenko NM. 2004. Primenenie topicheskih glyukokortikosteroidnyih gormonov v dermatologicheskoy praktike. Mistetstvo lIkuvannya 6:44–48

13. Allen BR. 2001. Review of atopic dermatitis literature. Atopy Reports: Atopic Dermatitis and Related Disorders 1(1):7–9.

14. Ayzdorov.ru (2014) Prichinyi, simptomyi, vidyi dermatita (http://www.ayzdorov.ru/lechenie_dermamit_chto.php).

15. Bailey JM. 1991. New mechanisms for effects of anti-inflammatory glucocorticoids. Biofactors 3(2):97–102. PMid:1832865

16. Barnes PJ. 2000. New directions in allergic diseases: mechanism-based anti-inflammatory therapies. J. Allergy Clin. Immunol. 106:5–16. https://doi.org/10.1067/mai.2000.107930; PMid:10887299

17. Bieber T, Leung DYM. 2009. Atopic dermatitis. Informa Healthcare, New York:466. https://doi.org/10.3109/9781420077995

18. Broeders JA, Ahmed Ali U, Fischer G. 2016, May 11. Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience. J. Am. Acad. Dermatol. Epub ahead of print.

19. Brunner PM, Khattri S, Garcet S et al. 2016, February 29. A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis. J. Allergy Clin. Immunol. Epub ahead of print. https://doi.org/10.1016/j.jaci.2015.12.1323

20. Jensen JM, Weppner M, Dдhnhardt-Pfeiffer S et al. 2013. Effects of pimecrolimus compared with triamcinolone acetonide cream on skin barrier structure in atopic dermatitis: a randomized, double-blind, right-left arm trial. Acta Derm. Venereol. 93(5):515–519. https://doi.org/10.2340/00015555-1533; PMid:23571785

21. Knol EF, Langeveld EA, van Reijsen FC et al. 1998. Allergic inflammation in atopic dermatitis. Ann. Dermatol. Venerol. 129:147. https://doi.org/10.1016/s0926-9959(98)94566-4

22. Siegfried EC, Jaworski JC, Kaiser JD, Hebert AA. 2016. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin. BMC Pediatr. 16(1):75. https://doi.org/10.1186/s12887-016-0607-9; PMid:27267134 PMCid:PMC4895880

23. Silverberg JI, Nelson DB, Yosipovitch G. 2016. Addressing treatment challenges in atopic dermatitis with novel topical therapies. J. Dermatolog. Treat. 11:1–9. https://doi.org/10.1080/09546634.2016.1174765; PMid:27165566

24. Stirling RG, Chung KF. 2000. New immunological approaches and cytokine targets in asthma and allergy. Eur. Respir. J. 16(6):1158–1174. https://doi.org/10.1034/j.1399-3003.2000.16f24.x; PMid:11292123